GRIFOLS | GRF - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Alcon AG USD 22.13B 99M 2026-03
Almirall EUR 1.53B 43.26M 2026-06
Amadeus IT EUR 4.57B 229.6M 2026-06
Amarin USD 443.62M 5.8M 2026-06
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bayer EUR 29.71B 863M 2026-06
Cie Automotive EUR 1.45B 46.93M 2025-12
Demant DKK 11.24B 1.4B 2026-06
Ence Energia y Celulosa EUR 545.2M 48.76M 2026-03
Essilor EUR 39.22B 329M 2026-06
Ferrovial EUR 7.4B 269M 2026-06
Fresenius EUR 19.7B 766M 2026-06
Fresenius Medical Care EUR 13.53B 673.44M 2026-06
Genmab DKK 5.96B 275M 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
GRIFOLS EUR 7.98B 2.52B 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Inditex 18.8B 1.84B 2025-09
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Merck EUR 30.17B 430M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Philips EUR 11.48B 84M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Smith & Nephew USD 5.18B 356M 2026-06
UCB EUR 10.87B 1.18B 2025-12
Viscofan EUR 911.32M 20.72M 2026-06